Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 15,221–15,240 of 17,987 drug recalls

Drug Recall Terminated Historical recordClass I

MiracleZEN Platinum, 1 pill blister pack, 2000 mg capsule, Distributed by: Power Life Distributors, COK Inc., Los Angeles, CA.

by Schindele Enterprises dba Midwest Wholesale

Reason
Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.
Recall initiated
January 9, 2014
Reported by FDA
May 28, 2014
Distribution
Distributed to PA, IL, TX, IA, GA, CT, FL, CA, LA, NY, MD, NV, and WI

View recall →

Drug Recall Terminated Historical recordClass I

SEXY MONKEY, 2000 mg, 1 count blister, Distributed by A Herbal Bio, Inc., Bayside, NY.

by Schindele Enterprises dba Midwest Wholesale

Reason
Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.
Recall initiated
January 9, 2014
Reported by FDA
May 28, 2014
Distribution
Distributed to PA, IL, TX, IA, GA, CT, FL, CA, LA, NY, MD, NV, and WI

View recall →

Drug Recall Terminated Historical recordClass I

BOOST ULTRA, sexual enhancement dietary supplement, 12-capsule/bottle. Also packaged in 3 pill bottles and 1 pill packs. BoostUtra.com, Springfield, MO.

by Schindele Enterprises dba Midwest Wholesale

Reason
Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.
Recall initiated
January 9, 2014
Reported by FDA
May 28, 2014
Distribution
Distributed to PA, IL, TX, IA, GA, CT, FL, CA, LA, NY, MD, NV, and WI

View recall →

Drug Recall Terminated Historical recordClass I

XZONE GOLD, 1 capsule blister 750 mg, Distributed by: XZONE, Orlando, FL.

by Schindele Enterprises dba Midwest Wholesale

Reason
Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.
Recall initiated
January 9, 2014
Reported by FDA
May 28, 2014
Distribution
Distributed to PA, IL, TX, IA, GA, CT, FL, CA, LA, NY, MD, NV, and WI

View recall →

Drug Recall Terminated Historical recordClass I

Esbelder Fem Mezcla con L-Carnitina Suplemento Alimenticio,30 capsule bottle, Hecho en Mexico: Soluciones HGC S. de R.L. de C.V. Av. Independencia #1060 Fracc. La Rinconada, Aguascalientes, Ags. Mex. C.P. 20136. UPC 7502011000251

by Herbal Give Care Llc

Reason
Marketed Without an Approved NDA/ANDA: Products found to contain undeclared sibutramine, N-Desmethylsibutramine, and N-di- Desmethylsibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.
Recall initiated
July 19, 2013
Reported by FDA
May 28, 2014
Distribution
Products were sold to distributors nationwide. Recalling firm sold some product directly to consumers.

View recall →

Drug Recall Terminated Historical recordClass I

Esbelder Man Herbal Blend With L-Carnitine Dietary Supplement, 30 capsule bottle, Made in Mexico: Soluciones S. de R.L. de C.V. Av. Independencia #1060 Fracc. La Rinconada, Aguascalientes, Ags. Mex. C.P. 20136. UPC 7502011000275

by Herbal Give Care Llc

Reason
Marketed Without an Approved NDA/ANDA: Products found to contain undeclared sibutramine, N-Desmethylsibutramine, and N-di- Desmethylsibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.
Recall initiated
July 19, 2013
Reported by FDA
May 28, 2014
Distribution
Products were sold to distributors nationwide. Recalling firm sold some product directly to consumers.

View recall →

Drug Recall Terminated Historical recordClass I

Esbelder Siloutte Suplemento Alimenticio, 30 capsule bottle, Hecho en Mexico Por: Herbal Give Care, Av Independencia # 1016, Fracc. La Rinconada, Aguascalientes, Ags. Mex. C.P. 20136. UPC 7502011000268

by Herbal Give Care Llc

Reason
Marketed Without an Approved NDA/ANDA: Products found to contain undeclared sibutramine, N-Desmethylsibutramine, and N-di- Desmethylsibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.
Recall initiated
July 19, 2013
Reported by FDA
May 28, 2014
Distribution
Products were sold to distributors nationwide. Recalling firm sold some product directly to consumers.

View recall →

Drug Recall Terminated Historical recordClass I

Esbelin Siloutte Te, Suplemento Alimenticio, herbal tea in a gold foil/plastic zip-lock pouch. Hecho en Mexico Por: Herbal Give Care, Av Independencia # 1016, Fracc. La Rinconada, Aguascalientes, Ags. Mex. C.P. 20136. UPC 7562684652553

by Herbal Give Care Llc

Reason
Marketed Without an Approved NDA/ANDA: Products found to contain undeclared sibutramine, N-Desmethylsibutramine, and N-di- Desmethylsibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.
Recall initiated
July 19, 2013
Reported by FDA
May 28, 2014
Distribution
Products were sold to distributors nationwide. Recalling firm sold some product directly to consumers.

View recall →

Drug Recall Terminated Historical recordClass I

Esbelin Siloutte Mezcal Herbal con L-Carnitine Suplemento Alimenticio, 30 capsule bottle, Hecho En Mexico Por: Soluciones HGC S. de R.L. de C.V. Av. Independicia #1016 Frac. La Rinconada Aguascalientes, Ags. Mex C.P. 20136, UPC 7502011000060

by Herbal Give Care Llc

Reason
Marketed Without an Approved NDA/ANDA: Products found to contain undeclared sibutramine, N-Desmethylsibutramine, and N-di- Desmethylsibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.
Recall initiated
July 19, 2013
Reported by FDA
May 28, 2014
Distribution
Products were sold to distributors nationwide. Recalling firm sold some product directly to consumers.

View recall →

Drug Recall Terminated Historical recordClass I

Effexor XR (venlafaxine HCl) Extended-Release Capsules, 150 mg, packaged in a) 30-count Unit of Use bottles (NDC 0008-0836-21) UPC 3 0008-0836-21 7; b) 90-count Unit of Use bottles (NDC 0008-0836-22) UPC 3 0008-0836-22 4; Rx only, Distributed by Wyeth Pharmaceuticals Inc., A subsidiary of Pfizer Inc., Philadelphia, PA 19101.

by Pfizer Us Pharmaceutical Group

Reason
Presence of Foreign Tablets/Capsules: A Pharmacist reported that a bottle of Effexor XR 150 mg capsules contained a single peach colored capsule printed TKN250 which was identified as a Tikosyn (dofetilide) capsule.
Recall initiated
March 6, 2014
Reported by FDA
May 28, 2014
Distribution
Nationwide and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass I

PRO ArthMax Dietary Supplement tablets, 750 mg, 120 count bottles, Distributed by Human Science Foundation, Los Angeles, CA

by HUMAN SCIENCE FOUNDATION

Reason
Marketed without an Approved NDA/ANDA; FDA analysis found the product to contain Chlorzoxazone, Nefopam, Diclofenac, Ibuprofen, Naproxen, and Indomethacin
Recall initiated
January 13, 2014
Reported by FDA
May 28, 2014
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass I

Acetylcysteine Solution, USP, 10%, 30 mL vial, Rx only, Ben Venue Laboratories, Inc., Bedford, OH, NDC 0054-3025-02

by Ben Venue Laboratories Inc

Reason
Presence of Particulate Matter: During a review of retain samples, the firm found a glass particulate in one lot of Acetylcysteine Solution
Recall initiated
February 14, 2014
Reported by FDA
May 28, 2014
Distribution
Nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

BUPRENORPHINE HYDROCHLORIDE Sublingual Tablets, 8 mg, 30-count bottles, Rx only, Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-5379-56, UPC 3 0093-5379-56 2.

by Teva Pharmaceuticals USA

Reason
Failed Impurities/Degradation Specifications: High out of specification impurity test results were obtained during stability testing.
Recall initiated
April 7, 2014
Reported by FDA
May 28, 2014
Distribution
Nationwide and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

BUPRENORPHINE HYDROCHLORIDE Sublingual Tablets, 2 mg, 30-count bottles, Rx only, Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-5378-56, UPC 3 0093-5378-56 5.

by Teva Pharmaceuticals USA

Reason
Failed Impurities/Degradation Specifications: High out of specification impurity test results were obtained during stability testing.
Recall initiated
April 7, 2014
Reported by FDA
May 28, 2014
Distribution
Nationwide and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Smart Tab First Aid ezRefill System Ibuprofen dispenser boxes (Item Number FAE 7014), 20 count boxes, First Aid Only Inc., Vancouver, WA

by First Aid Only Inc

Reason
First Aid Only, Inc is recalling Smart Tab First Aid ezRefill System Ibuprofen boxes and First Aid Cabinets containing these Ibuprofen boxes. Ibuprofen boxes (FAE 7014) were accidentally used to package aspirin packs (10 packs of 2 / 235mg tablets).
Recall initiated
March 25, 2014
Reported by FDA
May 21, 2014
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass I

REUMOFAN PLUS Tablets, 30 Tablet Bottles, OTC. Previene el cancer en los huesos, Nueva presentacion el original.

by Pain Free By Nature

Reason
Marketed Without an Approved NDA/ANDA; Product contains undeclared diclofenac and methocarbamol.
Recall initiated
March 13, 2014
Reported by FDA
May 21, 2014
Distribution
Nationwide including Puerto Rico

View recall →

Drug Recall Completed Historical recordClass II

Sterile Water for Injection, 5 mL ampoules, packaged in 50-count ampoules per box, Manufactured and Distributed by: Euro Med Laboratories, UPC 4800573016219

by Flawless Beauty LLC

Reason
Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling indicates it is to be used for parenteral injection.
Recall initiated
April 29, 2014
Reported by FDA
May 21, 2014
Distribution
Nationwide

View recall →

Drug Recall Completed Historical recordClass II

Vitamin C (ascorbic acid) Injection, USP, 500 mg per 2 mL, 50 x 2 mL ampoules per box, Manufactured by: TP Drug Laboratories (1969) Co., Ltd., 98 Soi Sukhumvlt 62, Yak 1, Bangchak, Prakanong, Bangkok 10260, Thailand, Reg. No. 1 A 1557/30; UPC 8 853533 000533

by Flawless Beauty LLC

Reason
Marketed Without An Approved NDA/ANDA: Parenteral product is sold over the counter whose labeling indicates it is to be used for the treatment of disease.
Recall initiated
April 29, 2014
Reported by FDA
May 21, 2014
Distribution
Nationwide

View recall →

Drug Recall Completed Historical recordClass II

Relumins Advanced Glutathione (lyophilized glutathione/vitamin C) injectable solution, 1500 mg/500 mg, packaged in 8-count vials, 8-count 5 mL vitamin C (ascorbic acid) solution diluent ampoules, and 30-count Advanced Glutathione Boosters capsules per box, Relumins Labs, 183 Locust Avenue, West Long Branch, NJ 07764, UPC 700175760302

by Flawless Beauty LLC

Reason
Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling indicates it is to be used parenterally for drug claims.
Recall initiated
April 29, 2014
Reported by FDA
May 21, 2014
Distribution
Nationwide

View recall →

Drug Recall Completed Historical recordClass II

Saluta (reduced glutathione) Powder for Injection, 600 mg/vial, packaged in 10 vials per box, Exclusively Distributed by: QAF Pharmaceuticals Inc. Philippines, Unit Unit 202 ECG Building, Multinational Avenue, Multinational Village, Parahaque City, Metro Manila Philippines; Manufactured by: Shandong Luye Pharmaceutical Co. Ltd, Yantai Shandong, PRC la Luye Pharma Subsidiary, UPC 6920425209014

by Flawless Beauty LLC

Reason
Marketed Without An Approved NDA/ANDA: Parenteral product is labeled for use as an antidote.
Recall initiated
April 29, 2014
Reported by FDA
May 21, 2014
Distribution
Nationwide

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.